TRPM8 and esophageal cancer: PD-L1 has been proposed as a prognostic predictor for human esophageal cancer (Chen et al., 2014; Yagi et al., 2019), and modulating TRPM8 channel activity with antagonist could be a pharmacological strategy to regulate PD-L1 effects in esophageal cells.